Sotera Health Company (SHC)
NASDAQ: SHC · Real-Time Price · USD
16.01
+0.14 (0.88%)
Nov 6, 2026, 4:00 PM EST - Market closed
Sotera Health Company Stock Forecast
Stock Price Forecast
According to 10 analysts polled by S&P Global, Sotera Health Company stock has a consensus rating of "Buy" and an average price target of $21.94. The average 1-year stock price forecast is 37.04% higher than the current stock price, while the lowest is $15 (-6.31%) and the highest is $25 (+56.15%).
Price Target: $21.94 (+37.04%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Sotera Health Company stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 2 | 2 | 2 | 2 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 10 | 10 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BMO Capital | BMO Capital | Buy Reiterates $22 | Buy | Reiterates | $22 | +37.41% | Nov 4, 2026 |
| RBC Capital | RBC Capital | Buy Reiterates $24 | Buy | Reiterates | $24 | +49.91% | Nov 4, 2026 |
| J.P. Morgan | J.P. Morgan | Sell Maintains $17 → $15 | Sell | Maintains | $17 → $15 | -6.31% | Nov 4, 2026 |
| Barclays | Barclays | Buy Maintains $22 → $20 | Buy | Maintains | $22 → $20 | +24.92% | Nov 4, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $25 | Buy | Maintains | $25 | +56.15% | Oct 19, 2026 |
Financial Forecast
Revenue This Year
1.25B
from 1.16B
Increased by 7.02%
Revenue Next Year
1.32B
from 1.25B
Increased by 5.71%
EPS This Year
0.99
from 0.86
Increased by 14.64%
EPS Next Year
1.08
from 0.99
Increased by 9.49%
EPS and Forward PE are based on non-GAAP adjusted numbers.